Reasons for Re-treatment Following Monovision Laser Refractive Surgery

医学 散光 眼科 回顾性队列研究 验光服务 外科 光学 物理
作者
Margarita Safir,Roni Kastin,Igor Kaiserman,Tzahi Sela,Gur Munzer,Michael Mimouni
出处
期刊:Journal of Refractive Surgery [Slack Incorporated (United States)]
卷期号:40 (11)
标识
DOI:10.3928/1081597x-20241010-01
摘要

Purpose To assess the incidence and causes for re-treatment following monovision laser refractive surgery in a large data study spanning a decade. Methods The setting for this retrospective comparative study was Care Vision Laser Center, Tel Aviv, Israel. This study included patients aged 36 to 60 years who underwent monovision laser vision correction at the Care Vision Laser Centers, Israel, from January 2012 to December 2022. Demographic, preoperative, and postoperative data were retrieved for analysis. Results Overall, 3,674 eyes of 1,847 patients were included. Re-treatment was performed in 1.28% (n = 47) of eyes, 0.84% (n = 31) distance-targeted and 0.44% (n = 16) near-targeted. Monovision reversal in near-targeted eyes occurred due to overcorrection (37.5%, n = 6 of 16), despite being on target (25%, n = 4 of 16), insufficient myopia (18.8%, n = 3 of 16), and de novo astigmatism (12.5%, n = 2 of 16). One eye was targeted for near vision due to de novo astigmatism. Re-treatment in distance-targeted eyes was due to myopic undercorrection (45.2%, n = 14 of 31), myopic regression (19.4%, n = 6 of 31), myopic overcorrection (12.9%, n = 4 of 31), hyperopic regression (6.5%, n = 2 of 31), astigmatism undercorrection (6.5%, n = 2 of 31), de novo astigmatism (6.5%, n = 2 of 31), and astigmatism regression (3.2%, n = 1 of 31). Re-treatment was more likely in distance targeted eyes of patients with monovision compared to near-targeted eyes ( P = .025) and patients without monovision ( P < .001). Conclusions In monovision laser vision correction, retreatment in the near-targeted eye is rare when the ideal near target (−1.50 to −1.25 diopters) is achieved. However, the distance-targeted eye is more likely to require re-treatment. Surgeons can plan monovision surgery and advise patients accordingly. [ J Refract Surg . 2024;40(11):e892–e897.]

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
刚刚
科研通AI2S的应助被胡萝卜卜采纳,获得10
1秒前
佳佳发布了新的文献求助10
1秒前
zhangzhang完成签到,获得积分10
1秒前
2秒前
2秒前
2秒前
幸运花花完成签到,获得积分10
2秒前
今后的应助被CHENHF采纳,获得10
3秒前
3秒前
Aurelia完成签到 ,获得积分20
3秒前
我是老大的应助被肥龙宝宝采纳,获得10
4秒前
G_Dragon完成签到 ,获得积分10
5秒前
pan完成签到 ,获得积分10
5秒前
星野发布了新的文献求助10
5秒前
5秒前
sanyazth完成签到,获得积分10
6秒前
悦耳的城发布了新的文献求助10
7秒前
7秒前
慕青的应助被Waitcy采纳,获得10
8秒前
默尧完成签到,获得积分10
8秒前
8秒前
8秒前
zjxnq完成签到 ,获得积分10
9秒前
fhg发布了新的文献求助10
9秒前
Xxin完成签到,获得积分10
10秒前
科目三的应助被晒个月亮采纳,获得10
10秒前
情怀的应助被changdingN采纳,获得10
10秒前
10秒前
安静的易绿完成签到,获得积分20
10秒前
Jigsaw发布了新的文献求助10
10秒前
耍酷的梦秋完成签到,获得积分10
10秒前
wan关注了科研通微信公众号
11秒前
Akim的应助被佳佳采纳,获得10
11秒前
12秒前
Duuu发布了新的文献求助10
12秒前
温柔的忆之完成签到,获得积分10
13秒前
共享精神的应助被科研通管家采纳,获得10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194239
求助须知:如何正确求助?哪些是违规求助? 9580103
关于积分的说明 21869458
捐赠科研通 7793840
什么是DOI,文献DOI怎么找? 3437562
关于科研通互助平台的介绍 2560983
邀请新用户注册赠送积分活动 2484332